PCR detects fungal DNA in keratitis

Article

Polymerase chain reaction (PCR) could be used to diagnose fungal keratitis.

Polymerase chain reaction (PCR) could be used to diagnose fungal keratitis, claims an investigation in the journal Eye.

A team led by Dr N. Tananuvat, Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, conducted a prospective nonrandomized study on 30 eyes of 30 patients with presumed fungal keratitis.

Each patient underwent corneal scraping and fungal-specific primers were used to analyse the specimens. PCR products were cloned and sequenced and compared to conventional microbial work-up.

PCR demonstrated positivity in 93.3%, culture in 40% and potassium hydroxide in 20% of the total patients included in the study. Out of the 28 PCR-positive patients, 12 were culture-positive and 16 were culture-negative.

There were no false-negative results in the culture-positive specimens recorded by the PCR, suggesting it is able to accurately detect fungal DNA in a high percentage of culture-negative cases. The procedure could be helpful, in addition to smear and culture in the efficient diagnosis of fungal keratitis.

Please click here to read the abstract.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.